Predict your next investment

HEALTHCARE | Drug Development
najittech.com

See what CB Insights has to offer

Founded Year

2008

Stage

Grant | Alive

Total Raised

$3.1M

Last Raised

$3.1M | 2 yrs ago

About Najit Technologies

Najit Technologies works to develop a yellow fever vaccine in humans.

Najit Technologies Headquarter Location

15232 NW Greenbrier Parkway

Beaverton, Oregon, 97006,

United States

971-727-3568

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Najit Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Najit Technologies is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Najit Technologies Patents

Najit Technologies has filed 1 patent.

The 3 most popular patent topics include:

  • Animal viral diseases
  • Animal virology
  • Hemorrhagic fevers
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/10/2017

8/18/2020

Animal viral diseases, Vaccines, Viral diseases, Hemorrhagic fevers, Animal virology

Grant

Application Date

5/10/2017

Grant Date

8/18/2020

Title

Related Topics

Animal viral diseases, Vaccines, Viral diseases, Hemorrhagic fevers, Animal virology

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.